Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPG | Q9Y5X9 | 6/20 | 0.37 |
| ▸ | LPL | P06858 | 5/20 | 0.37 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.33 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.33 |
| ▸ | CYSLTR1 | Q9Y271 | 2/20 | 0.33 |
| ▸ | TYR | P14679 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | HTT | P42858 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27946363 | 0.85 | LPL (0.42) | LIPGLPLCYSLTR2CYSLTR1 | |
| SCHEMBL16139822 | 0.82 | LIPG (0.52) | LIPGLPLACE2CYSLTR2CYSLTR1 | |
| SCHEMBL1108971 | 0.82 | LIPG (0.52) | LIPGLPLACE2CYSLTR2CYSLTR1 | |
| SCHEMBL12264421 | 0.82 | LIPG (0.52) | LIPGLPLACE2CYSLTR2CYSLTR1 | |
| SCHEMBL30460 | 0.82 | LIPG (0.52) | LIPGLPLACE2CYSLTR2CYSLTR1 | |
| SCHEMBL12610496 | 0.82 | LIPG (0.52) | LIPGLPLACE2CYSLTR2CYSLTR1 | |
| SCHEMBL20037354 | 0.76 | LIPG (0.44) | LIPGLPLCYSLTR2CYSLTR1TYR | |
| SCHEMBL12407973 | 0.76 | LPL (0.30) | LIPGLPLACE2 | |
| SCHEMBL12890197 | 0.76 | LIPG (0.38) | LIPGLPLACE2TYRMEN1 | |
| SCHEMBL12651429 | 0.75 | LIPG (0.37) | LIPGLPLCYSLTR2CYSLTR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7973172-B2 | Organic compound, semiconductor film electrode employing the organic compound, photoelectric conversion element employing the organic compound, and photoelectrochemical solar cell employing the organic compound | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2011-07-05 | — | — | US | disclosed |
| US-20100174095-A1 | ORGANIC COMPOUND, SEMICONDUCTOR FILM ELECTRODE EMPLOYING THE ORGANIC COMPOUND, PHOTOELECTRIC CONVERSION ELEMENT EMPLOYING THE ORGANIC COMPOUND, AND PHOTOELECTROCHEMICAL SOLAR CELL EMPLOYING THE ORGANIC COMPOUND | NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) | 2010-07-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100174095-A1 | ORGANIC COMPOUND, SEMICONDUCTOR FILM ELECTRODE EMPLOYING THE ORGANIC COMPOUND, PHOTOELECTRIC CONVERSION ELEMENT EMPLOYING THE ORGANIC COMPOUND, AND PHOTOELECTROCHEMICAL SOLAR CELL EMPLOYING THE ORGANIC COMPOUND | HCN3, HCN4, HCN2 | LIPG 2969/4885LPL 4095/4885ACE2 3311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.